Affiliation:
1. University of Ulsan College of Medicine
2. Asan Medical Center
3. Pusan National University School of Medicine
Abstract
AbstractBackground:Parkin dysfunction associated with the progression of parkinsonism contributes to a progressive systemic skeletal disease characterized by low bone mineral density. However, the role of parkin in bone remodeling has not yet been elucidated in detail.Result:We observed that decreased parkin in monocytes is linked to osteoclastic bone-resorbing activity. siRNA-mediated knockdown of parkin significantly enhanced the bone-resorbing activity of osteoclasts (OCs) on dentin without any changes in osteoblast differentiation. Moreover,Parkin-deficient mice exhibited an osteoporotic phenotype with a lower bone volume accompanied by increased OC-mediated bone-resorbing capacity displaying increased acetylation of α-tubulin compared to wild-type (WT) mice. Notably, compared to WT mice, theParkin-deficient mice displayed increased susceptibility to inflammatory arthritis, reflected by a higher arthritis score and a marked bone loss after arthritis induction using K/BxN serum transfer, but not ovariectomy-induced bone loss. Intriguingly, parkin colocalized with microtubules and parkin-depleted-osteoclast precursor cells (Parkin-/-OCPs) displayed augmented ERK-dependent acetylation of α-tubulin due to failure of interaction with histone deacetylase 6 (HDAC6), which was promoted by IL-1β signaling. The ectopic expression of parkin inParkin-/-OCPs limited the increase in dentin resorption induced by IL-1β, accompanied by the reduced acetylation of α-tubulin and diminished cathepsin K activity.Conclusion:These results indicate that a deficiency in the function of parkin caused by a decrease in parkin expression in OCPs under the inflammatory condition may enhance inflammatory bone erosion by altering microtubule dynamics to maintain OC activity.
Publisher
Research Square Platform LLC
Reference62 articles.
1. Gnadinger M, Mellinghoff HU, Kaelin-Lang A. Parkinson's Disease and the Bones. Swiss medical weekly (2011) 141:w13154. Epub 2011/02/18. doi: 10.4414/smw.2011.13154.
2. Osteoporosis and Parkinson's Disease. Clinical cases in mineral and bone metabolism: the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases;Raglione LM,2011
3. Osteoporosis in Parkinson's Disease;Invernizzi M;Parkinsonism Relat Disord,2009
4. Relationship between Osteopenia and Clinical Characteristics of Parkinson's Disease;Ishizaki F;Mov disorders: official J Mov Disorder Soc,1993
5. [Bone Changes in Parkinson's Disease];Ishizaki F;No to shinkei,1993